Tech Company Financing Transactions
NABsys Funding Round
Stata Venture Partners and private investors participated in a $7 million Series B capital raise for NABsys. The round was announced on 2/17/2010.
Transaction Overview
Company Name
Announced On
2/17/2010
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors
Stata Venture Partners (Lead Investor) (Raymond Stata)
Proceeds Purpose
The funding will be used to accelerate the development and commercialization of the company's proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
60 Clifford St.
Providence, RI 02903
USA
Providence, RI 02903
USA
Phone
Website
Email Address
Overview
NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barrett Bready
Chief Technical Officer
John Oliver
Vice President
Michael Kaiser
VP - Bus. Development
Brian Paras
VP - Product Management
Steve Nurnberg
Browse more venture capital transactions:
Prev: 2/16/2010: Viewfinity venture capital transaction
Next: 2/17/2010: Sesen Bio venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs